Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fludarabine with Pegylated Liposomal Doxorubicin in Platinum-Resistant Ovarian Cancer
NCT03335241Phase 2Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Mar 2017
- Primary completion
- Dec 2021
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of fludarabine in ovarian cancer, sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
fludarabine
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT03335241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03335241.